Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia.

Ahn, So Yoon; Chang, Yun Sil; Lee, Myung Hee; Sung, Sein; Kim, Ai-Rhan; Park, Won Soon

Ahn, So Yoon; Chang, Yun Sil; Lee, Myung Hee; Sung, Sein; Kim, Ai-Rhan; Park, Won Soon.

Afiliação

Ahn SY; Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Chang YS; Cell and Gene Therapy Institute, Samsung Medical Center, Seoul, South Korea.
Lee MH; Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Sung S; Cell and Gene Therapy Institute, Samsung Medical Center, Seoul, South Korea.
Kim AR; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Park WS; Social Information Research Institute, Seoul, South Korea.

Thorax ; 78(11): 1105-1110, 2023 11.

Article em En | MEDLINE | ID: mdl-37604693

Assuntos

Displasia Broncopulmonar; Recém-Nascido; Lactente; Humanos; Displasia Broncopulmonar/terapia; Seguimentos; Estudos Prospectivos; Células Estromais; Oxigênio/uso terapêutico

Palavras-chave

critical care; paediatric lung disaese

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans / Infant / Newborn Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google